Yanguanjia Breath Analyzer NA Series

A range of diagnostic products based on breath analysis technology for various health conditions. The product line is designed for non-invasive disease screening and early detection.

A portable device that measures oxygen gas concentration, carbon dioxide concentration, and respiratory volume accompanying respiration. It enables scientific measurement of metabolic function through analysis of these parameters.

A high-precision nitric oxide (NO) measurement device designed for detecting NO and non-oxygen carbon dioxide in exhaled gas. The eNoglow series includes models LN1000, LN2000, LN3000, and LN4000, with a measurement range of 0-5000ppb and a resolution of 0.01ppb. It is a Class II medical device registered with China's NMPA and designed to meet the high standards required in clinical settings such as pediatrics, cardiology, and intensive care units.

Nanoparticle-based exhaled breath analysis system for disease screening and biomarker detection. Enables non-invasive respiratory and systemic disease evaluation. Integrated analysis algorithms for automated interpretation.

Portable breath analyzer for non-invasive detection and measurement of volatile organic compounds and biomarkers in exhaled breath. Applicable in respiratory diagnostics, metabolic screening, and point-of-care testing environments. Provides rapid analysis with minimal patient preparation required.

Non-invasive point-of-care assessment device for airway inflammation that combines high-sensitivity biosensor technology (0.1 ppb) with full ATS/ERS compliance. It delivers multi-parameter results including FeNO, CaNO, and FnNO in under one minute, with a patented dual-channel design that ensures complete protection against cross-contamination.

The NObreath® FeNO device measures fractional exhaled nitric oxide (FeNO) to assess airway inflammation and aid in asthma diagnosis and management. This non-invasive breath test conforms to BTS/NICE/SIGN, ATS, and ERS guidelines and is suitable for both adult and pediatric patients. The device includes ambient NO monitoring capability for environmental assessment.

The WLD801 is a non-invasive analyzer that measures exhaled nitric oxide (FeNO) levels to assess airway inflammation in respiratory conditions such as asthma and allergic rhinitis. It provides rapid, objective diagnostic support for clinicians in pulmonology and allergy departments. The device delivers quantitative results with high sensitivity and specificity for patient management.

Fractional exhaled nitric oxide (FeNO) measurement system for non-invasive assessment of airway inflammation. Utilized in diagnosis and monitoring of asthma, COPD, and chronic respiratory conditions with high-precision sensing technology.

Diagnostic system detecting nitric oxide in exhaled breath to evaluate airway inflammation and diagnose primary ciliary dyskinesia. Provides non-invasive assessment of respiratory tract conditions.

A diagnostic device for measuring nitric oxide (NO) levels in exhaled breath, available in models Reslink R100 and Reslink R200. It has a measurement range of 1-3500ppb and is a Class II medical device certified by China's NMPA. The device is used for assisting in the diagnosis and assessment of conditions such as asthma and chronic obstructive pulmonary disease, as well as for monitoring disease progression.

A medical device used to measure nitric oxide and carbon dioxide levels in human exhaled breath. It supports both oral and nasal breathing modes with a measurement range of 1ppb to 3500ppb, enabling detection of airway inflammation and respiratory conditions.